Brexit
Brexit/ R&D/ Views & Analysis/ Views and analysis
What will a no-deal Brexit mean for pharma and healthcare?
X
What will a no-deal Brexit mean for pharma and healthcare?
https://pharmaphorum.com/views-and-analysis/what-will-a-no-deal-brexit-mean-for-pharma-and-healthcare/
X
EMA set for official move from London on 1 March
https://pharmaphorum.com/news/ema-set-official-move-london/
Brexit/ Sales and Marketing/ Views & Analysis/ Views and analysis
Brexit and beyond: the challenges ahead for pharma
X
Brexit and beyond: the challenges ahead for pharma
https://pharmaphorum.com/views-analysis-sales-marketing/brexit-challenges-ahead-pharma/
X
Pharma calls for ‘no deal’ preparation after Brexit deal rejected
https://pharmaphorum.com/news/pharma-calls-for-no-deal-preparation-after-brexit-deal-rejected/
X
Brexit affecting supplies of generic drugs, say pharmacists
https://pharmaphorum.com/news/brexit-affecting-supplies-of-generic-drugs-say-pharmacists/
Brexit/ News/ News/ Oncology/ Top stories
Ipsen warns over medicine supplies amid Brexit uncertainty
Richard Staines
Brexit, cancer, Ipsen, Liver cancer
0 Comment
X
Ipsen warns over medicine supplies amid Brexit uncertainty
https://pharmaphorum.com/news/ipsen-warns-over-medicine-supplies-amid-brexit-uncertainty/
X
Pharma companies warned over ‘no deal’ Brexit disruption
https://pharmaphorum.com/news/pharma-companies-warned-over-no-deal-brexit-disruption/
Brexit/ Market Access/ Views & Analysis/ Views and analysis
Pharma hopes for best, fears the worst, as Brexit vote nears
X
Pharma hopes for best, fears the worst, as Brexit vote nears
https://pharmaphorum.com/views-analysis-market-access/pharma-hopes-best-fears-worst-brexit-vote-nears/